VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation

Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur...

Full description

Saved in:
Bibliographic Details
Published inAdvances in cancer research Vol. 138; pp. 41 - 69
Main Authors Fang, Diana, Maldonado, Eduardo N
Format Journal Article
LanguageEnglish
Published United States 2018
Subjects
Online AccessGet full text
ISSN2162-5557
0065-230X
2162-5557
DOI10.1016/bs.acr.2018.02.002

Cover

Abstract Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress.
AbstractList Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress.
Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH2 that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress.Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH2 that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential (ΔΨ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ-Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC-tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC-tubulin interaction promotes cell death by a "double-hit model" characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress.
Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype in cancer cells. The flux of respiratory substrates, ADP, and Pi into mitochondria and the release of mitochondrial ATP to the cytosol occur through voltage-dependent anion channels (VDACs) located in the mitochondrial outer membrane. Catabolism of respiratory substrates in the Krebs cycle generates NADH and FADH 2 that enter the electron transport chain (ETC) to generate a proton motive force that maintains mitochondrial membrane potential ( ΔΨ ) and is utilized to generate ATP. The ETC is also the major cellular source of mitochondrial reactive oxygen species (ROS). αβ -Tubulin heterodimers decrease VDAC conductance in lipid bilayers. High constitutive levels of cytosolic free tubulin in intact cancer cells close VDAC decreasing mitochondrial ΔΨ and mitochondrial metabolism. The VDAC–tubulin interaction regulates VDAC opening and globally controls mitochondrial metabolism, ROS formation, and the intracellular flow of energy. Erastin, a VDAC-binding molecule lethal to some cancer cell types, and erastin-like compounds identified in a high-throughput screening antagonize the inhibitory effect of tubulin on VDAC. Reversal of tubulin inhibition of VDAC increases VDAC conductance and the flux of metabolites into and out of mitochondria. VDAC opening promotes a higher mitochondrial ΔΨ and a global increase in mitochondrial metabolism leading to high cytosolic ATP/ADP ratios that inhibit glycolysis. VDAC opening also increases ROS production causing oxidative stress that, in turn, leads to mitochondrial dysfunction, bioenergetic failure, and cell death. In summary, antagonism of the VDAC–tubulin interaction promotes cell death by a “double-hit model” characterized by reversion of the proproliferative Warburg phenotype (anti-Warburg) and promotion of oxidative stress.
Author Fang, Diana
Maldonado, Eduardo N
AuthorAffiliation Medical University of South Carolina, Charleston, SC, United States
Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States
AuthorAffiliation_xml – name: Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States
– name: Medical University of South Carolina, Charleston, SC, United States
Author_xml – sequence: 1
  givenname: Diana
  surname: Fang
  fullname: Fang, Diana
  organization: Medical University of South Carolina, Charleston, SC, United States
– sequence: 2
  givenname: Eduardo N
  surname: Maldonado
  fullname: Maldonado, Eduardo N
  email: maldona@musc.edu
  organization: Medical University of South Carolina, Charleston, SC, United States; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States. Electronic address: maldona@musc.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29551129$$D View this record in MEDLINE/PubMed
BookMark eNpVkEtLxDAUhYOMOA_9Ay4kSzetSdokjQthrE8YUXRwW9I0nYl0mpqkgv_eoqOMq3vhnvsdzpmCUWtbDcAxRjFGmJ2VPpbKxQThLEYkRojsgQnBjESUUj7a2cdg6v3bIOAZzg7AmAhKMSZiAi5fr-Y5fNarvpHB2PYczuGDCVatbVs5Ixu4lG6lAwwWvgTbwVw3DXxytjG1dt8vh2C_lo3XR9s5A8ub62V-Fy0eb-_z-SLqCGMhSphgsiqllJyzOi15kqZlxVSNSsmR4rWuRKo5xbzOdKbKjHNBiUwUYSkRKJmBix9s15cbXSndBiebonNmI91nYaUp_l9asy5W9qNgJEkFZwPgdAtw9r3XPhQb49UQR7ba9r4YeqQpEkNng_Rk1-vP5Le35Avse3LU
ContentType Journal Article
Copyright 2018 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2018 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/bs.acr.2018.02.002
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2162-5557
EndPage 69
ExternalDocumentID PMC6234976
29551129
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA184456
– fundername: NIGMS NIH HHS
  grantid: P20 GM103542
GroupedDBID ---
--K
-~X
.GJ
0R~
23M
34R
3O-
53G
5GY
5RE
85S
8N7
8NA
8NF
AAXUO
AAYSV
ABGWT
ABMAC
ABQQC
ABSWN
ACGFS
ACXMD
AENEX
AFFNX
AFOST
AFTJW
AGAMA
AHMUE
AI.
AJBBN
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
C45
CGR
CS3
CUY
CVF
ECM
EIF
F5P
FDB
FEDTE
HVGLF
HZ~
JDP
L7B
MVM
NEJ
NPM
O9-
OVD
P2P
SBF
SDK
SES
SHL
TEORI
UDS
VH1
VQP
WH7
X7N
ZGI
ZXP
7X8
AALRI
5PM
ID FETCH-LOGICAL-p266t-3696adbaaa776f4b7344bd6cf0ba70c7fed94e7517f8e8cb877952a3c2642903
ISSN 2162-5557
0065-230X
IngestDate Thu Aug 21 18:24:15 EDT 2025
Fri Jul 11 11:03:06 EDT 2025
Thu Apr 03 07:02:24 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Oxidative stress
Mitochondria
Tubulin
Cancer metabolism
Glycolysis
Erastin
Voltage-dependent anion channel
Warburg effect
Language English
License 2018 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p266t-3696adbaaa776f4b7344bd6cf0ba70c7fed94e7517f8e8cb877952a3c2642903
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 29551129
PQID 2015409162
PQPubID 23479
PageCount 29
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6234976
proquest_miscellaneous_2015409162
pubmed_primary_29551129
PublicationCentury 2000
PublicationDate 2018-00-00
20180101
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – year: 2018
  text: 2018-00-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Advances in cancer research
PublicationTitleAlternate Adv Cancer Res
PublicationYear 2018
SSID ssj0027818
Score 2.5257735
SecondaryResourceType review_article
Snippet Cancer metabolism is emerging as a chemotherapeutic target. Enhanced glycolysis and suppression of mitochondrial metabolism characterize the Warburg phenotype...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 41
SubjectTerms Animals
Antineoplastic Agents - pharmacology
Cell Proliferation - drug effects
Energy Metabolism
Humans
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondria - pathology
Neoplasms - drug therapy
Neoplasms - metabolism
Neoplasms - pathology
Voltage-Dependent Anion Channels - metabolism
Title VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation
URI https://www.ncbi.nlm.nih.gov/pubmed/29551129
https://www.proquest.com/docview/2015409162
https://pubmed.ncbi.nlm.nih.gov/PMC6234976
Volume 138
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BKiEuFdACKQ8tUm-VkePsw-YW2kYRVXooofQW7cstEthR6l749czsbuyEBgm4WJZtbaT5xpNvxzPfEHIIFEOnTBVJzoVNmLIsQfnbpBTWgBMpyw02Ck_PxeQL-3TFr7pxf767pNHvzc-tfSX_gypcA1yxS_YfkG0XhQtwDvjCERCG419hfHkyQgNdxxFcoct8Cu8oxLTK-nkcM1_pjQzzc1Mvjo59qg4n9ZRu2YGykqENBQG-RNbg2fIoigG1SeNxzC-fgFu1EX2qvltg9NanXU8tel0dv_HEhEKMfs6HnGwgYGvKg2R0Gx-D_EqMcEGm6l7gDTkAfQtegCqrgzwooWbrD4MVFj88FFnBPdHr_oTa0sDVrYdkJ5NywHtkZ3R28fWs20UDxYjdT1iod_8nUd85LrJt2_B79esanZg9IbtxH0BHAdSn5IGrnpFH01jpsEc-Ira0w_YDHdENZGlAljY1RWQpIks3kN0ns_Hp7HiSxHkXyQJoUpPgaEVltVJKSlEyLYeMaStMmWolUyNLZwvmJB_IMne50bmUBc_U0ACpzYp0-Jz0qrpyLwm1IpWqTEsHdJwpZ_LcWK6EtUzDfpIVffJuZZc5hBP8RqQqV9_dzjPk1MAhRdYnL4Kd5ougezJfWbVP5IYF2wdQqnzzTvXtxkuWA8lmQHwP_rjmK_IYIQzJrdek1yzv3Buge41-Gx3gFyt_Vj8
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=VDAC+Regulation%3A+A+Mitochondrial+Target+to+Stop+Cell+Proliferation&rft.jtitle=Advances+in+cancer+research&rft.au=Fang%2C+Diana&rft.au=Maldonado%2C+Eduardo+N&rft.date=2018&rft.eissn=2162-5557&rft.volume=138&rft.spage=41&rft_id=info:doi/10.1016%2Fbs.acr.2018.02.002&rft_id=info%3Apmid%2F29551129&rft.externalDocID=29551129
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-5557&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-5557&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-5557&client=summon